About Clontech
Clontech is a company based in Palo Alto (United States) founded in 1984 was acquired by Takara Bio in July 2005. Clontech offers products and services including Kits, Reagents, and Instruments. Clontech operates in a competitive market with competitors including Quanterix, Biocare Medical, Merck, Neogen and Parse Biosciences, among others.
- Headquarter Palo Alto, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Takara Bio Usa, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Takara Bio
& 1 more
-
Employee Count
Not available
-
Acquired by
Takara Bio
(Jul 01, 2005)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Clontech
Clontech offers a comprehensive portfolio of products and services, including Kits, Reagents, and Instruments.
Tools for gene discovery and nucleic acid purification
Substances for PCR and CRISPR applications
Devices for single-cell sequencing and analysis
Funding Insights of Clontech
Investors in Clontech
Clontech has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Takara Bio and Summit Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Summit Partners is recognized as a growth equity investment firm.
|
Locked | Locked | Locked | |
|
Developer of gene-based therapies as well as contract services for the industrial and agricultural sector
|
Locked | Locked | Locked |
Investor details for Clontech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Clontech
Investment portfolio details for Clontech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Clontech
Detailed financials for Clontech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Clontech Comparisons
Peer comparison for Clontech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Clontech
Clontech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quanterix, Biocare Medical, Merck, Neogen and Parse Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| Locked | Locked | Locked |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| Locked | Locked | Locked |
Merck is engaged in science and technology solutions globally.
|
|
| Locked | Locked | Locked |
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
|
|
| Locked | Locked | Locked |
RNA-sequencing transcriptome kits for health data analysis are developed.
|
|
| Locked | Locked | Locked |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
Detailed competitors of Clontech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Clontech
Complete news archive for Clontech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clontech
Clontech was founded in 1984 and raised its 1st funding round 15 years after it was founded.
Clontech is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Clontech was founded in 1984 in Palo Alto, United States, within the life science sector. Reagents, instruments, and services are supplied for research applications. Products encompass PCR reagents, RT enzymes, library construction kits, cloning kits, and nucleic acidprotein purification tools. Services include gene discovery, protein analysis, plant and food research, and RNAi studies. Acquisition by Takara Bio was completed on July 1, 2005.
Clontech's top competitors include Neogen, Biocare Medical and Merck.
Clontech offers Kits, Reagents, and Instruments.
Clontech has 2 investors. Key investors include Takara Bio, and Summit Partners.